Composition for Preventing or Treating Benign Prostatic Hyperplasia Comprising High Maysin Corn Silk Extract

The present invention relates to a novel use of maysin, which is for preventing or treating benign prostatic hyperplasia. A composition containing maysin or a corn silk extract as an active component inhibits the expression of 5α reductase 2 mRNA in prostate to reduce a concentration of 5α-R2, there...

Full description

Saved in:
Bibliographic Details
Main Authors KANG HYUN JOONG, KIM WOOKYOUNG, KIM SUN RIM, KIM MYUNG HWAN
Format Patent
LanguageEnglish
Korean
Published 14.03.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a novel use of maysin, which is for preventing or treating benign prostatic hyperplasia. A composition containing maysin or a corn silk extract as an active component inhibits the expression of 5α reductase 2 mRNA in prostate to reduce a concentration of 5α-R2, thereby inhibiting a conversion of testosterone to DHT to inhibit benign prostatic hyperplasia induced by testosterone. Therefore, the composition can be usefully used for preventing or treating benign prostatic hyperplasia. 본 발명은 메이신의 새로운 용도인 전립선 비대증의 예방 또는 치료용도에 관한 것으로, 메이신 또는 옥수수수염 추출물을 유효성분으로 함유하는 조성물은 전립선에서 5α 리덕타제 2(5α reductase 2) mRNA 발현을 억제하여 5α-R2 농도를 감소시켜 테스토스테론이 DHT로 전환되는 것을 억제함으로써 테스토스테론으로 유발된 전립선비대를 억제시킬 수 있어 전립선 비대증의 예방 또는 치료에 유용하게 사용할 수 있다.
Bibliography:Application Number: KR20170132332